← Database
Bioregulator Peptide

Pinealon

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

One of the Khavinson short "bioregulator" peptides (a family that also includes Cartalax, Vilon, Thymogen, Ovagen, Chonluten, Vesugen and others) marketed for tissue-specific effects. Evidence is sparse and largely from a single research tradition.

How it works

Pinealon is a three-amino-acid peptide from the same Russian 'bioregulator' family as Epitalon (which also includes Cartalax, Vilon, Thymogen, Ovagen, and others), promoted for brain-protective effects.

The family shares a single proposed mechanism: that these very short peptides enter cells, bind DNA, and switch specific tissue genes on or off. For Pinealon specifically the claimed benefit is neuroprotection.

As with the rest of the family, the evidence is sparse and low-quality and the mechanism isn't independently established — so this is best read as a research curiosity rather than a validated therapeutic.

Mechanism · Detailed Analysis
Proposed targetAn EDR tripeptide of the Khavinson "bioregulator" family, sharing the proposed gene-regulatory hypothesis (DNA binding / tissue-specific expression).
Evidence & caveatsEvidence is sparse and low-quality; the mechanism is not independently established. The same caveat applies across the family (Cartalax, Vilon, Thymogen, Ovagen, and others).
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.